Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

K. Kotseva, D. Wood, D. De Bacquer, G. De Backer, L. Rydén, C. Jennings, V. Gyberg, P. Amouyel, J. Bruthans, A. Castro Conde, R. Cífková, JW. Deckers, J. De Sutter, M. Dilic, M. Dolzhenko, A. Erglis, Z. Fras, D. Gaita, N. Gotcheva, J. Goudevenos,...

. 2016 ; 23 (6) : 636-648. [pub] 20150216

Language English Country England, Great Britain

Document type Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

Grant support
NT13186 MZ0 CEP Register

AIMS: To determine whether the Joint European Societies guidelines on cardiovascular prevention are being followed in everyday clinical practice of secondary prevention and to describe the lifestyle, risk factor and therapeutic management of coronary patients across Europe. METHODS AND RESULTS: EUROASPIRE IV was a cross-sectional study undertaken at 78 centres from 24 European countries. Patients <80 years with coronary disease who had coronary artery bypass graft, percutaneous coronary intervention or an acute coronary syndrome were identified from hospital records and interviewed and examined ≥ 6 months later. A total of 16,426 medical records were reviewed and 7998 patients (24.4% females) interviewed. At interview, 16.0% of patients smoked cigarettes, and 48.6% of those smoking at the time of the event were persistent smokers. Little or no physical activity was reported by 59.9%; 37.6% were obese (BMI ≥ 30 kg/m(2)) and 58.2% centrally obese (waist circumference ≥ 102 cm in men or ≥88 cm in women); 42.7% had blood pressure ≥ 140/90 mmHg (≥140/80 in people with diabetes); 80.5% had low-density lipoprotein cholesterol ≥ 1.8 mmol/l and 26.8% reported having diabetes. Cardioprotective medication was: anti-platelets 93.8%; beta-blockers 82.6%; angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75.1%; and statins 85.7%. Of the patients 50.7% were advised to participate in a cardiac rehabilitation programme and 81.3% of those advised attended at least one-half of the sessions. CONCLUSION: A large majority of coronary patients do not achieve the guideline standards for secondary prevention with high prevalences of persistent smoking, unhealthy diets, physical inactivity and consequently most patients are overweight or obese with a high prevalence of diabetes. Risk factor control is inadequate despite high reported use of medications and there are large variations in secondary prevention practice between centres. Less than one-half of the coronary patients access cardiac prevention and rehabilitation programmes. All coronary and vascular patients require a modern preventive cardiology programme, appropriately adapted to medical and cultural settings in each country, to achieve healthier lifestyles, better risk factor control and adherence with cardioprotective medications.

Cardiac Rehabilitation Unit Cardiology Department Hospital Universitario La Paz Madrid Spain

Cardiology Unit Department of Medicine Solna Karolinska Institutet Stockholm Sweden

Clinical Trial Centre Würzburg University Hospital Würzburg Germany

Comprehensive Heart Failure Centre and Department of Medicine 1 University of Würzburg Germany

Comprehensive Heart Failure Centre University of Würzburg

Department of Cardiology National Heart Hospital Sofia Bulgaria

Department of Cardiology Shupyk's National Medical Academy of Postgraduate Education Kiev Ukraine

Department of Heart Failure and Valve Disease Skåne University Hospital Lund Sweden

Heart and Vascular Medicine of Vilnius University Hospital Santariskiu Clinics Vilnius Lithuania

Institut Pasteur de Lille Université de Lille France

Institute of Clinical Epidemiology and Biometry University of Würzburg

Jagiellonian University Medical College Faculty of Health Sciences Department of Epidemiology and Population Studies Kracow Poland

Kuopio University Hospital Finland

National Research Centre for Preventive Medicine of the Ministry of Healthcare of the Russian Federation Moscow Russia

The Adelaide and Meath Hospital Dublin Ireland

The European Society of Cardiology Sophia Antipolis Cedex France Cardiology Department of Medical School University of Ioannina Greece

The European Society of Cardiology Sophia Antipolis Cedex France Cardiology Unit Department of Medicine Solna Karolinska Institutet Stockholm Sweden

The European Society of Cardiology Sophia Antipolis Cedex France Centre for Cardiovascular Prevention 1st Medical Faculty Charles University and Thomayer Hospital Prague Czech Republic

The European Society of Cardiology Sophia Antipolis Cedex France Centre for Medical Research School of Medicine University of Banja Luka Bosnia and Herzegovina

The European Society of Cardiology Sophia Antipolis Cedex France Clinic for Internal Medicine Intermedica Nis Serbia

The European Society of Cardiology Sophia Antipolis Cedex France Clinic of Cardiovascular Diseases of Vilnius University

The European Society of Cardiology Sophia Antipolis Cedex France Clinical Centre University of Sarajevo Bosnia and Herzegovina

The European Society of Cardiology Sophia Antipolis Cedex France Department of Internal Medicine University of Ghent Belgium

The European Society of Cardiology Sophia Antipolis Cedex France Department of Public Health University of Ghent Belgium

The European Society of Cardiology Sophia Antipolis Cedex France Federal Health Centre and Department of Chronic Noncommunicable Diseases Prevention National Research Centre for Preventive Medicine Moscow Russia

The European Society of Cardiology Sophia Antipolis Cedex France Hacettepe University Ankara Turkey

The European Society of Cardiology Sophia Antipolis Cedex France International Centre for Circulatory Health National Heart and Lung Institute Imperial College London UK

The European Society of Cardiology Sophia Antipolis Cedex France Thoraxcentre's Department of Cardiology Rotterdam The Netherlands

The European Society of Cardiology Sophia Antipolis Cedex France Universitatea de Medicina si Farmacie 'Victor Babes' Institutul de Boli Cardiovasculare Timisoara Romania

The European Society of Cardiology Sophia Antipolis Cedex France University Hospital Centre Zagreb School of Medicine University of Zagreb Zagreb Croatia

The European Society of Cardiology Sophia Antipolis Cedex France University Medical Centre Ljubljana Slovenia

The European Society of Cardiology Sophia Antipolis Cedex France University of Latvia Pauls Stradins Clinical University Hospital Riga Latvia

The European Society of Cardiology Sophia Antipolis Cedex France University of Nicosia Medical School Nicosia General Hospital Cyprus

The European Society of Cardiology Sophia Antipolis Cedex France University of Zagreb School of Medicine and University Hospital Centre Zagreb Croatia

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17001200
003      
CZ-PrNML
005      
20170523163344.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/2047487315569401 $2 doi
024    7_
$a 10.1177/2047487315569401 $2 doi
035    __
$a (PubMed)25687109
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kotseva, Kornelia $u The European Society of Cardiology, Sophia Antipolis Cedex, France International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, UK k.kotseva@imperial.ac.uk.
245    10
$a EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries / $c K. Kotseva, D. Wood, D. De Bacquer, G. De Backer, L. Rydén, C. Jennings, V. Gyberg, P. Amouyel, J. Bruthans, A. Castro Conde, R. Cífková, JW. Deckers, J. De Sutter, M. Dilic, M. Dolzhenko, A. Erglis, Z. Fras, D. Gaita, N. Gotcheva, J. Goudevenos, P. Heuschmann, A. Laucevicius, S. Lehto, D. Lovic, D. Miličić, D. Moore, E. Nicolaides, R. Oganov, A. Pajak, N. Pogosova, Z. Reiner, M. Stagmo, S. Störk, L. Tokgözoğlu, D. Vulic, . ,
520    9_
$a AIMS: To determine whether the Joint European Societies guidelines on cardiovascular prevention are being followed in everyday clinical practice of secondary prevention and to describe the lifestyle, risk factor and therapeutic management of coronary patients across Europe. METHODS AND RESULTS: EUROASPIRE IV was a cross-sectional study undertaken at 78 centres from 24 European countries. Patients <80 years with coronary disease who had coronary artery bypass graft, percutaneous coronary intervention or an acute coronary syndrome were identified from hospital records and interviewed and examined ≥ 6 months later. A total of 16,426 medical records were reviewed and 7998 patients (24.4% females) interviewed. At interview, 16.0% of patients smoked cigarettes, and 48.6% of those smoking at the time of the event were persistent smokers. Little or no physical activity was reported by 59.9%; 37.6% were obese (BMI ≥ 30 kg/m(2)) and 58.2% centrally obese (waist circumference ≥ 102 cm in men or ≥88 cm in women); 42.7% had blood pressure ≥ 140/90 mmHg (≥140/80 in people with diabetes); 80.5% had low-density lipoprotein cholesterol ≥ 1.8 mmol/l and 26.8% reported having diabetes. Cardioprotective medication was: anti-platelets 93.8%; beta-blockers 82.6%; angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75.1%; and statins 85.7%. Of the patients 50.7% were advised to participate in a cardiac rehabilitation programme and 81.3% of those advised attended at least one-half of the sessions. CONCLUSION: A large majority of coronary patients do not achieve the guideline standards for secondary prevention with high prevalences of persistent smoking, unhealthy diets, physical inactivity and consequently most patients are overweight or obese with a high prevalence of diabetes. Risk factor control is inadequate despite high reported use of medications and there are large variations in secondary prevention practice between centres. Less than one-half of the coronary patients access cardiac prevention and rehabilitation programmes. All coronary and vascular patients require a modern preventive cardiology programme, appropriately adapted to medical and cultural settings in each country, to achieve healthier lifestyles, better risk factor control and adherence with cardioprotective medications.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a kardiologie $x trendy $7 D002309
650    _2
$a kardiovaskulární látky $x terapeutické užití $7 D002317
650    _2
$a komorbidita $7 D015897
650    _2
$a koronární nemoc $x diagnóza $x epidemiologie $x terapie $7 D003327
650    _2
$a průřezové studie $7 D003430
650    _2
$a dieta $x škodlivé účinky $7 D004032
650    _2
$a cvičení $7 D015444
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dodržování směrnic $7 D019983
650    _2
$a průzkumy zdravotní péče $7 D019538
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a lékařská praxe - způsoby provádění $x trendy $7 D010818
650    _2
$a prevalence $7 D015995
650    _2
$a prospektivní studie $7 D011446
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    12
$a chování snižující riziko $7 D040242
650    _2
$a sekundární prevence $x trendy $7 D055502
650    _2
$a sedavý životní styl $7 D057185
650    _2
$a kouření $x škodlivé účinky $7 D012907
650    _2
$a odvykání kouření $7 D016540
650    12
$a společnosti lékařské $7 D012955
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Wood, David $u The European Society of Cardiology, Sophia Antipolis Cedex, France International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, UK.
700    1_
$a De Bacquer, Dirk $u The European Society of Cardiology, Sophia Antipolis Cedex, France Department of Public Health, University of Ghent, Belgium.
700    1_
$a De Backer, Guy $u The European Society of Cardiology, Sophia Antipolis Cedex, France Department of Public Health, University of Ghent, Belgium.
700    1_
$a Rydén, Lars $u The European Society of Cardiology, Sophia Antipolis Cedex, France Cardiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Jennings, Catriona $u The European Society of Cardiology, Sophia Antipolis Cedex, France International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, UK.
700    1_
$a Gyberg, Viveca $u Cardiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Amouyel, Philippe $u Institut Pasteur de Lille, Université de Lille, France. $7 gn_A_00005735
700    1_
$a Bruthans, Jan, $u The European Society of Cardiology, Sophia Antipolis Cedex, France Centre for Cardiovascular Prevention, 1st Medical Faculty Charles University and Thomayer Hospital, Prague, Czech Republic. $d 1948- $7 jn20000810219
700    1_
$a Castro Conde, Almudena $u Cardiac Rehabilitation Unit, Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.
700    1_
$a Cífková, Renata, $u The European Society of Cardiology, Sophia Antipolis Cedex, France Centre for Cardiovascular Prevention, 1st Medical Faculty Charles University and Thomayer Hospital, Prague, Czech Republic. $d 1955- $7 nlk20010094490
700    1_
$a Deckers, Jaap W $u The European Society of Cardiology, Sophia Antipolis Cedex, France Thoraxcentre's Department of Cardiology, Rotterdam, The Netherlands.
700    1_
$a De Sutter, Johan $u The European Society of Cardiology, Sophia Antipolis Cedex, France Department of Internal Medicine, University of Ghent, Belgium.
700    1_
$a Dilic, Mirza $u The European Society of Cardiology, Sophia Antipolis Cedex, France Clinical Centre University of Sarajevo, Bosnia and Herzegovina.
700    1_
$a Dolzhenko, Maryna $u Department of Cardiology, Shupyk's National Medical Academy of Postgraduate Education, Kiev, Ukraine.
700    1_
$a Erglis, Andrejs $u The European Society of Cardiology, Sophia Antipolis Cedex, France University of Latvia, Pauls Stradins Clinical University Hospital, Riga, Latvia.
700    1_
$a Fras, Zlatko $u The European Society of Cardiology, Sophia Antipolis Cedex, France University Medical Centre, Ljubljana, Slovenia.
700    1_
$a Gaita, Dan $u The European Society of Cardiology, Sophia Antipolis Cedex, France Universitatea de Medicina si Farmacie 'Victor Babes', Institutul de Boli Cardiovasculare, Timisoara, Romania.
700    1_
$a Gotcheva, Nina $u Department of Cardiology, National Heart Hospital, Sofia, Bulgaria.
700    1_
$a Goudevenos, John $u The European Society of Cardiology, Sophia Antipolis Cedex, France Cardiology Department of Medical School University of Ioannina, Greece.
700    1_
$a Heuschmann, Peter $u Institute of Clinical Epidemiology and Biometry, University of Würzburg; Comprehensive Heart Failure Centre, University of Würzburg; Clinical Trial Centre Würzburg, University Hospital Würzburg, Germany.
700    1_
$a Laucevicius, Aleksandras $u The European Society of Cardiology, Sophia Antipolis Cedex, France Clinic of Cardiovascular Diseases of Vilnius University; Heart and Vascular Medicine of Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
700    1_
$a Lehto, Seppo $u Kuopio University Hospital, Finland.
700    1_
$a Lovic, Dragan $u The European Society of Cardiology, Sophia Antipolis Cedex, France Clinic for Internal Medicine Intermedica, Nis, Serbia.
700    1_
$a Miličić, Davor $u The European Society of Cardiology, Sophia Antipolis Cedex, France University of Zagreb School of Medicine & University Hospital Centre Zagreb, Croatia.
700    1_
$a Moore, David $u The Adelaide and Meath Hospital, Dublin, Ireland.
700    1_
$a Nicolaides, Evagoras $u The European Society of Cardiology, Sophia Antipolis Cedex, France University of Nicosia Medical School, Nicosia General Hospital, Cyprus.
700    1_
$a Oganov, Raphael $u National Research Centre for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
700    1_
$a Pajak, Andrzej $u Jagiellonian University Medical College, Faculty of Health Sciences, Department of Epidemiology and Population Studies, Kracow, Poland.
700    1_
$a Pogosova, Nana $u The European Society of Cardiology, Sophia Antipolis Cedex, France Federal Health Centre and Department of Chronic Noncommunicable Diseases Prevention, National Research Centre for Preventive Medicine, Moscow, Russia.
700    1_
$a Reiner, Zeljko $u The European Society of Cardiology, Sophia Antipolis Cedex, France University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
700    1_
$a Stagmo, Martin $u Department of Heart Failure and Valve Disease, Skåne University Hospital, Lund, Sweden.
700    1_
$a Störk, Stefan $u Comprehensive Heart Failure Centre and Department of Medicine I, University of Würzburg, Germany.
700    1_
$a Tokgözoğlu, Lale $u The European Society of Cardiology, Sophia Antipolis Cedex, France Hacettepe University, Ankara, Turkey.
700    1_
$a Vulic, Dusko $u The European Society of Cardiology, Sophia Antipolis Cedex, France Centre for Medical Research, School of Medicine, University of Banja Luka, Bosnia and Herzegovina.
700    1_
$a ,
773    0_
$w MED00188754 $t European journal of preventive cardiology $x 2047-4881 $g Roč. 23, č. 6 (2016), s. 636-648
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25687109 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170523163739 $b ABA008
999    __
$a ok $b bmc $g 1180340 $s 961767
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 23 $c 6 $d 636-648 $e 20150216 $i 2047-4881 $m European journal of preventive cardiology $n Eur J Prev Cardiol $x MED00188754
GRA    __
$a NT13186 $p MZ0
LZP    __
$a Pubmed-20170103

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...